| Dissecting the treatment-naive ecosystem of human melanoma brain metastasis J Biermann, JC Melms, AD Amin, Y Wang, LA Caprio, A Karz, S Tagore, ... Cell 185 (14), 2591-2608. e30, 2022 | 117 | 2022 |
| Multiscale engineering of immune cells and lymphoid organs S Kim, SB Shah, PL Graney, A Singh Nature Reviews Materials 4 (6), 355-378, 2019 | 80 | 2019 |
| Cellular self-assembly and biomaterials-based organoid models of development and diseases SB Shah, A Singh Acta biomaterialia 53, 29-45, 2017 | 70 | 2017 |
| Ex vivo synthetic immune tissues with T cell signals for differentiating antigen-specific, high affinity germinal center B cells A Purwada, SB Shah, W Béguelin, A August, AM Melnick, A Singh Biomaterials 198, 27-36, 2019 | 59 | 2019 |
| Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypes H Scholze, RE Stephenson, R Reynolds, S Shah, R Puri, SD Butler, ... Blood advances 4 (20), 5226-5231, 2020 | 44 | 2020 |
| How biophysical forces regulate human B cell lymphomas F Apoorva, AM Loiben, SB Shah, A Purwada, L Fontan, R Goldstein, ... Cell reports 23 (2), 499-511, 2018 | 42 | 2018 |
| Modular immune organoids with integrin ligand specificity differentially regulate ex vivo B cell activation A Purwada, SB Shah, W Beguelin, AM Melnick, A Singh ACS Biomaterials Science & Engineering 3 (2), 214-225, 2017 | 40 | 2017 |
| A robust method to generate mechanically anisotropic vascular smooth muscle cell sheets for vascular tissue engineering DE Backman, BL LeSavage, SB Shah, JY Wong Macromolecular bioscience 17 (6), 1600434, 2017 | 38 | 2017 |
| Identification of MALT1 feedback mechanisms enables rational design of potent antilymphoma regimens for ABC-DLBCL L Fontan, R Goldstein, G Casalena, M Durant, MR Teater, J Wilson, ... Blood, The Journal of the American Society of Hematology 137 (6), 788-800, 2021 | 35 | 2021 |
| The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity P Ho, JC Melms, M Rogava, CJ Frangieh, J Poźniak, SB Shah, Z Walsh, ... Cancer Cell 41 (7), 1207-1221. e12, 2023 | 30 | 2023 |
| Combinatorial treatment rescues tumour-microenvironment-mediated attenuation of MALT1 inhibitors in B-cell lymphomas SB Shah, CR Carlson, K Lai, Z Zhong, G Marsico, KM Lee, NE Félix Vélez, ... Nature Materials 22 (4), 511-523, 2023 | 28 | 2023 |
| Creating artificial lymphoid tissues to study immunity and hematological malignancies SB Shah, A Singh Current opinion in hematology 24 (4), 377-383, 2017 | 18 | 2017 |
| Profiling Germinal Center-like B Cell Responses to Conjugate Vaccines Using Synthetic Immune Organoids TD Moeller, SB Shah, K Lai, N Lopez-Barbosa, P Desai, W Wang, ... ACS Central Science 9 (4), 787-804, 2023 | 8 | 2023 |
| The CD58: CD2 axis is co-regulated with PD-L1 via CMTM6 and governs anti-tumor immunity P Ho, JC Melms, M Rogava, CJ Frangieh, SB Shah, Z Walsh, O Kyrysyuk, ... bioRxiv, 2022.03. 21.485049, 2022 | 7 | 2022 |
| Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens ZH Walsh, P Shah, N Kothapalli, SB Shah, G Nikolenyi, DZ Brodtman, ... Nature Biotechnology, 1-12, 2024 | 4 | 2024 |
| Bioengineered organoid models of human germinal centers N Quizon, K Kwak, S Shah, A Singh, S Pierce The Journal of Immunology 200 (1_Supplement), 120.14-120.14, 2018 | 3 | 2018 |
| Human immune organoids to decode B cell response in healthy donors and patients with lymphoma Z Zhong, M Quiñones-Pérez, Z Dai, VM Juarez, E Bhatia, CR Carlson, ... Nature Materials, 1-15, 2024 | 2 | 2024 |
| micronuclAI: Automated quantification of micronuclei for assessment of chromosomal instability. MA Ibarra-Arellano, LA Caprio, A Hada, N Stotzem, L Cai, S Shah, ... bioRxiv, 2024.05. 24.595722, 2024 | 1 | 2024 |
| Massively parallel base-editing screens to map variant effects on anti-tumor hallmarks of primary human T cells and improve cell-based cancer immunotherapies ZH Walsh, P Shah, N Kothapalli, G Nikolenyi, S Shah, G Leuzzi, N Vasan, ... Cancer Research 84 (6_Supplement), 15-15, 2024 | | 2024 |
| Massively parallel base editing screens to map variant effects on anti-tumor hallmarks of primary human T cells ZH Walsh, P Shah, N Kothapalli, G Nikolenyi, S Shah, G Leuzzi, M Mu, ... bioRxiv, 2023.12. 13.571465, 2023 | | 2023 |